Luminex Corporation

(LMNX) Trade

By |

Profile

Luminex Corp is a United States based company that develops, manufactures and sells proprietary biological testing technologies and products with applications throughout the life sciences industries, including diagnostics, pharmaceutical, and research. Its products include MAGPIX, Luminex 100/200, and FLEXMAP 3D. Their key market segments are molecular infectious disease, genetic or inherited disease, human leukocyte antigen (HLA) transplant diagnostics, immunodiagnostics, and life sciences research. It offers various solutions in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, and food safety.

Contact Information

Website: www.luminexcorp.com
Email: hcurrie@luminexcorp.com
Main Phone: +1 512 219-8020
Address: 12212 Technology Boulevard
Address 2: Suite 130
State: TX
City / Town: Austin
Country: USA
Postal Code: 78727

Issuer Information

Exchange: NGS
CEO: Nachum Shamir
Employees: 1247
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)(541714)

Equities News

Profile

Luminex Corp is a United States based company that develops, manufactures and sells proprietary biological testing technologies and products with applications throughout the life sciences industries, including diagnostics, pharmaceutical, and research. Its products include MAGPIX, Luminex 100/200, and FLEXMAP 3D. Their key market segments are molecular infectious disease, genetic or inherited disease, human leukocyte antigen (HLA) transplant diagnostics, immunodiagnostics, and life sciences research. It offers various solutions in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, and food safety.

Contact Information

Website: www.luminexcorp.com
Email: hcurrie@luminexcorp.com
Main Phone: +1 512 219-8020
Address: 12212 Technology Boulevard
Address 2: Suite 130
State: TX
City / Town: Austin
Country: USA
Postal Code: 78727

Issuer Information

Exchange: NGS
CEO: Nachum Shamir
Employees: 1247
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)(541714)

Equities News

$ 33.37 $ 1.05 (3.23%)
Last Price 33.37 Change $ 1.05 Change % 3.23 Tick N/A
Bid 25.00 Bid Size 400.00 Ask 40.00 Ask Size 100.00
Open 32.46 High 33.56 Low 32.46 Prev Close 32.32
Last Trade Volume 516,395 52 Wk Hi 40.21 52 Wk Low 17.35
Market Cap 1.5 bi Ex-Div Date Div Rate 0.36 Yield 1.0790
Shares 45,789,869.00 EPS (TTM) -0.15 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 5 40
Number of Buys 2 9
Number of Sells 3 31
Net Activity -36962 -161607
Last 10 Buys Shares
Harriss T. Currie 1,000
Richard W Rew 1,000
Nachum Shamir 1,000
Walter Loewenbaum 1,000
Nachum Shamir 1,000
Walter Loewenbaum 1,000
Walter Loewenbaum 1,000
Walter Loewenbaum 1,000
Walter Loewenbaum 1,000
Walter Loewenbaum 1,000
Last 10 Sell Shares
Walter Loewenbaum 1,000
Todd C. Bennett 1,000
Walter Loewenbaum 1,000
Walter Loewenbaum 1,000
Walter Loewenbaum 1,000
Walter Loewenbaum 1,000
Walter Loewenbaum 1,000
Walter Loewenbaum 1,000
Walter Loewenbaum 1,000
Robert J. Cresci 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 24 24 24 24
Low Target Price Estimate 19 19 19 19
Mean Target Price Estimate 21.6 21.6 21.6 21.6
Standard Deviation 1.82 1.82 1.82 1.82
Date of Most Recent Estimate 05/08/18 05/08/18 05/08/18 05/08/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 5 5 4 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 1 1
Mean Rec. 2.67 2.67 3 3